MERCHAVIA BIOTECH VENTURE FUND INVESTS IN RMDY!

Image

2017 was a phenomenal year for us with installations of our DIY Digital Therapeutics platform across the globe, serving many needs like management programs for Diabetes, DPP, Heart Health, HIV Medication Management, Oncology, Rehab, Employee Wellness and Weight Loss among many others. Some of those installations are with the world’s leading health stakeholders like Medtronic, IBM Watson, and AHA.

To fuel our growth in 2018 we have just closed an investment led by Merchavia, a public biotech Israeli venture group, and will enable us to grow our sales efforts and further invest in our platform to offer a one-stop shop for creating sophisticated white-label Digital Therapeutics programs.